Marshall accelerates production of life-saving device

Marshall Aerospace and Defence Group (MADG) has reached an agreement with UK manufacturer Portsmouth Aviation that will accelerate production of  negative pressure ventilation assistance devices by sharing knowledge and prototypes it developed in partnership with the exovent consortium of academics and medics who initially identified the potential for the application of the technology in the global battle against Covid-19.

The non-invasive exovent prototype negative pressure ventilation assistance device was developed to provide additional treatment options for patient with respiratory conditions in a critical care environment, including those with COVID-19, with the benefit of offering greater patient comfort as they don’t need to be asleep or have an artificial airway in place.

Read more